oral pregnenolone supplementation only pushes flux down the pregnane pathway, and without touching 17,20-lyase (DHEAS shift aside) it raises progesterone, allopregnanolone and PregS. also contrary to what people assume, it doesn't produce any glucocorticoid effect.

in osteoclasts it selectively suppresses ERK, killing the Fos to NFATc1 axis and RANKL-induced ROS (freezing RANKL-driven fusion at the mononuclear stage), and effectively shuts down resorption. on top of that it upregulates anabolic transcription factors in bone



separately, pregnenolone and progesterone both suppress FSH-induced aromatase activity

and to be clear, all of this is limited to what pregnenolone does directly as a molecule. the systemic effects coming from pregnane conversion could of course be different, and bigger (progesterone as a BONE-TROPHIC hormone).

in osteoclasts it selectively suppresses ERK, killing the Fos to NFATc1 axis and RANKL-induced ROS (freezing RANKL-driven fusion at the mononuclear stage), and effectively shuts down resorption. on top of that it upregulates anabolic transcription factors in bone



separately, pregnenolone and progesterone both suppress FSH-induced aromatase activity

and to be clear, all of this is limited to what pregnenolone does directly as a molecule. the systemic effects coming from pregnane conversion could of course be different, and bigger (progesterone as a BONE-TROPHIC hormone).